Finance

Lists
Why is T5O up 11,11%?
Dive Deeper
T5O:FRA
bioXXmed AG
€1,00
+11,11%
(+0,10) 1D
5 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for T5O...
Open
€0,92
High
€1,00
Low
€0,92
Mkt. cap
271,87 k
Avg. vol.
44,00
Volume
39,00
52-wk high
€1,36
52-wk low
€0,76
EPS
-€6,72
Shares outstanding
2,33 m
No. of employees
2
Open
€0,92
High
€1,00
Low
€0,92
Mkt. cap
271,87 k
Avg. vol.
44,00
Volume
39,00
52-wk high
€1,36
52-wk low
€0,76
EPS
-€6,72
Shares outstanding
2,33 m
No. of employees
2
News stories
From web sources and news partners
About bioXXmed AG
CEO-
Employees2
Founded2000
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-134,00
-134,00
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,67 k
8,67 k
8,50 k
8,50 k
Operating expense
5,98 k
5,98 k
36,50 k
36,50 k
Total operating expenses
5,98 k
5,98 k
36,50 k
36,50 k
Operating income
-6,11 k
-6,11 k
-36,50 k
-36,50 k
Other non operating income
3,72 k
3,72 k
1,50 k
1,50 k
EBT including unusual items
-54,74 k
-54,74 k
-37,50 k
-37,50 k
EBT excluding unusual items
-4,74 k
-4,74 k
-37,50 k
-37,50 k
Income tax expense
-46,00
-46,00
-
-
Effective tax rate
0,08%
0,08%
-
-
Other operating expenses
43,79 k
43,79 k
28,00 k
28,00 k
Net income
-54,70 k
-54,70 k
-37,50 k
-37,50 k
Net profit margin
40 817,16%
40 817,16%
-
-
Earnings per share
-
-
-
-
Interest and investment income
38,00
38,00
500,00
500,00
Interest expense
-2,38 k
-2,38 k
-3,00 k
-3,00 k
Net interest expenses
-2,34 k
-2,34 k
-2,50 k
-2,50 k
Depreciation and amortization charges
-46,48 k
-46,48 k
-
-
EBITDA
-6,09 k
-6,10 k
-36,49 k
-36,49 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme